These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1191 related items for PubMed ID: 19319950

  • 1. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
    Wingate PJ, McAulay KA, Anthony IC, Crawford DH.
    J Med Virol; 2009 May; 81(5):870-7. PubMed ID: 19319950
    [Abstract] [Full Text] [Related]

  • 2. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.
    Ohga S, Nomura A, Takada H, Tanaka T, Furuno K, Takahata Y, Kinukawa N, Fukushima N, Imai S, Hara T.
    J Med Virol; 2004 Nov; 74(3):449-58. PubMed ID: 15368517
    [Abstract] [Full Text] [Related]

  • 3. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
    Sugaya N, Kimura H, Hara S, Hoshino Y, Kojima S, Morishima T, Tsurumi T, Kuzushima K.
    J Infect Dis; 2004 Sep 01; 190(5):985-8. PubMed ID: 15295706
    [Abstract] [Full Text] [Related]

  • 4. CD4(+) T-cell responses to Epstein-Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV-associated non-Hodgkin lymphoma: Th1 in active disease but Tr1 in remission.
    Marshall NA, Culligan DJ, Johnston PW, Millar C, Barker RN, Vickers MA.
    Br J Haematol; 2007 Oct 01; 139(1):81-9. PubMed ID: 17854310
    [Abstract] [Full Text] [Related]

  • 5. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
    Tosato G, Straus S, Henle W, Pike SE, Blaese RM.
    J Immunol; 1985 May 01; 134(5):3082-8. PubMed ID: 2984282
    [Abstract] [Full Text] [Related]

  • 6. [Virological and immunological studies on inapparent Epstein-Barr virus infection in healthy individuals: in comparison to immunosuppressed patients and patients with infectious mononucleosis].
    Imai S.
    Hokkaido Igaku Zasshi; 1990 Sep 01; 65(5):481-92. PubMed ID: 2172132
    [Abstract] [Full Text] [Related]

  • 7. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK, Haworth SJ, Cohen J, Mundin J, Rickinson A, Sissons JG.
    Q J Med; 1986 Feb 01; 58(226):111-21. PubMed ID: 3012622
    [Abstract] [Full Text] [Related]

  • 8. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis.
    Tosato G, Magrath I, Koski I, Dooley N, Blaese M.
    N Engl J Med; 1979 Nov 22; 301(21):1133-7. PubMed ID: 226884
    [Abstract] [Full Text] [Related]

  • 9. Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient.
    Piriou ER, van Dort K, Weel JF, Bemelman FJ, Gamadia LE, van Oers MH, van Baarle D.
    Clin Immunol; 2006 Apr 22; 119(1):16-20. PubMed ID: 16386961
    [Abstract] [Full Text] [Related]

  • 10. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis.
    Wang F, Blaese RM, Zoon KC, Tosato G.
    J Clin Invest; 1987 Jan 22; 79(1):7-14. PubMed ID: 3025263
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection.
    Ohga S, Nomura A, Takada H, Ihara K, Kawakami K, Yanai F, Takahata Y, Tanaka T, Kasuga N, Hara T.
    J Infect Dis; 2001 Jan 01; 183(1):1-7. PubMed ID: 11106535
    [Abstract] [Full Text] [Related]

  • 12. B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis.
    Al Tabaa Y, Tuaillon E, Jeziorski E, Ouedraogo DE, Bolloré K, Rubbo PA, Foulongne V, Rodière M, Vendrell JP.
    J Clin Virol; 2011 Sep 01; 52(1):33-7. PubMed ID: 21684200
    [Abstract] [Full Text] [Related]

  • 13. Clinical and immunological considerations in Epstein-Barr virus-associated diseases.
    Andersson J.
    Scand J Infect Dis Suppl; 1996 Sep 01; 100():72-82. PubMed ID: 8860357
    [Abstract] [Full Text] [Related]

  • 14. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN, Tang AZ, Zhou L, Huang GW, Wang Z, Zeng Y.
    Chin Med J (Engl); 2009 May 20; 122(10):1173-8. PubMed ID: 19493466
    [Abstract] [Full Text] [Related]

  • 15. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
    Ladell K, Dorner M, Zauner L, Berger C, Zucol F, Bernasconi M, Niggli FK, Speck RF, Nadal D.
    Cell Microbiol; 2007 Aug 20; 9(8):2055-69. PubMed ID: 17419714
    [Abstract] [Full Text] [Related]

  • 16. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P, Vervoort MB, Aarbiou J, van Dissel P, Brink A, Bloemena E, Meijer CJ, Middeldorp JM.
    J Infect Dis; 1999 May 20; 179(5):1108-15. PubMed ID: 10191211
    [Abstract] [Full Text] [Related]

  • 17. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
    Tosato G, Magrath IT, Blaese RM.
    J Immunol; 1982 Feb 20; 128(2):575-9. PubMed ID: 6274959
    [Abstract] [Full Text] [Related]

  • 18. T cell cytokine profile during primary Epstein-Barr virus infection (infectious mononucleosis).
    Attarbaschi T, Willheim M, Ramharter M, Hofmann A, Wahl K, Winkler H, Graninger W, Winkler S.
    Eur Cytokine Netw; 2003 Feb 20; 14(1):34-9. PubMed ID: 12799212
    [Abstract] [Full Text] [Related]

  • 19. CD8 lymphocytes during Epstein Barr virus (EBV) infection: A CD29 positive population is expanded in acute infectious mononucleosis.
    de Paoli P, Gennari D, Reitano M, Martelli P, Sacilotto C, Comoretto R, Santini G.
    Allergol Immunopathol (Madr); 1991 Feb 20; 19(2):95-7. PubMed ID: 1722959
    [Abstract] [Full Text] [Related]

  • 20. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
    Klein E, Ernberg I, Masucci MG, Szigeti R, Wu YT, Masucci G, Svedmyr E.
    Cancer Res; 1981 Nov 20; 41(11 Pt 1):4210-5. PubMed ID: 6272964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.